Symposium at Termis 2026: Accelerating multidisciplinary innovation to close the gap in clinical translation

At the conference TERMIS EU-Chapter “Accelerating multidisciplinary innovation to close the gap in clinical translation” from April 21 to 24, 2026 in Palma de Mallorca, Dr. Constanze Zwies will lead a symposium titled “Recombinant proteins for tissue engineering applications”. 

Proteins as essential component of the extracellular matrix are of significant importance for physiological wound healing and the artificial reproduction of tissue by forming an optimal scaffold for cell growth, binding important signaling molecules and presenting peptide-motifs that control cell differentiation. In contrast to natural protein-based materials in tissue engineering e.g., Collagen, GelMA and Fibronectin, recombinant proteins can be a great benefit. Their potential for medical applications can be increased immensely through their genetic modification. With the design of artificial proteins via biomimetic approaches or even AI-based techniques we can expand the sequence-space that nature does not use in order to find new and improved functionalities according to the special needs of the biomaterial.
This symposium will deal with the opportunities that bioengineering and biotechnological approaches enable. Which protein motifs are promising and are used for different applications within the TERM already? How can AI-based methods like Rosetta help us to create even better performing materials?